Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iRhythm Holdings (IRTC) Cash from Investing Activities (2016 - 2025)

iRhythm Holdings (IRTC) has disclosed Cash from Investing Activities for 11 consecutive years, with -$48.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities rose 60.05% to -$48.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$277.1 million, a 125.28% decrease, with the full-year FY2025 number at -$277.1 million, down 125.28% from a year prior.
  • Cash from Investing Activities was -$48.8 million for Q4 2025 at iRhythm Holdings, up from -$89.2 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $117.0 million in Q1 2021 to a low of -$122.2 million in Q4 2024.
  • A 5-year average of -$17.4 million and a median of -$8.3 million in 2022 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: skyrocketed 2190.26% in 2023, then tumbled 8825.64% in 2024.
  • iRhythm Holdings' Cash from Investing Activities stood at -$27.1 million in 2021, then skyrocketed by 70.1% to -$8.1 million in 2022, then surged by 117.25% to $1.4 million in 2023, then crashed by 8825.64% to -$122.2 million in 2024, then soared by 60.05% to -$48.8 million in 2025.
  • Per Business Quant, the three most recent readings for IRTC's Cash from Investing Activities are -$48.8 million (Q4 2025), -$89.2 million (Q3 2025), and -$100.9 million (Q2 2025).